NYSE:PKI - PerkinElmer Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$75.47 +1.07 (+1.44 %)
(As of 05/20/2018 04:00 PM ET)
Previous Close$75.47
Today's Range$74.38 - $75.58
52-Week Range$61.50 - $84.49
Volume389,978 shs
Average Volume634,327 shs
Market Capitalization$8.35 billion
P/E Ratio26.02
Dividend Yield0.37%
Beta0.84

About PerkinElmer (NYSE:PKI)

PerkinElmer logoPerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, food, and laboratory services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment develops and offers analytical technologies, solutions, and services for the environmental market that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. It also provides solutions to farmers and food producers; an analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries; and laboratory services. In addition, this segment offers a suite of solutions comprising reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market. The Diagnostics segment provides instruments, reagents, and software test and screen products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used in diagnosing genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for use in applications covering oncology, genetic testing, and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. has a collaboration agreement with Helix. The company was founded in 1931 and is headquartered in Waltham, Massachusetts.

Receive PKI News and Ratings via Email

Sign-up to receive the latest news and ratings for PKI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
SymbolNYSE:PKI
CUSIP71404610
Phone781-663-6900

Debt

Debt-to-Equity Ratio0.73
Current Ratio1.33
Quick Ratio0.93

Price-To-Earnings

Trailing P/E Ratio26.02
Forward P/E Ratio20.91
P/E Growth1.73

Sales & Book Value

Annual Sales$2.26 billion
Price / Sales3.70
Cash Flow$3.9246 per share
Price / Cash19.23
Book Value$23.10 per share
Price / Book3.27

Profitability

EPS (Most Recent Fiscal Year)$2.90
Net Income$292.63 million
Net Margins11.73%
Return on Equity13.26%
Return on Assets6.17%

Miscellaneous

Employees11,000
Outstanding Shares110,630,000

PerkinElmer (NYSE:PKI) Frequently Asked Questions

What is PerkinElmer's stock symbol?

PerkinElmer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PKI."

How often does PerkinElmer pay dividends? What is the dividend yield for PerkinElmer?

PerkinElmer announced a quarterly dividend on Thursday, April 26th. Investors of record on Friday, July 20th will be given a dividend of $0.07 per share on Friday, August 10th. This represents a $0.28 annualized dividend and a yield of 0.37%. The ex-dividend date of this dividend is Thursday, July 19th. View PerkinElmer's Dividend History.

How were PerkinElmer's earnings last quarter?

PerkinElmer (NYSE:PKI) announced its quarterly earnings data on Monday, April, 30th. The medical research company reported $0.63 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.61 by $0.02. The medical research company had revenue of $644 million for the quarter, compared to the consensus estimate of $618.97 million. PerkinElmer had a return on equity of 13.26% and a net margin of 11.73%. The firm's revenue for the quarter was up 0 compared to the same quarter last year. During the same period last year, the company posted $0.55 earnings per share. View PerkinElmer's Earnings History.

When is PerkinElmer's next earnings date?

PerkinElmer is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for PerkinElmer.

What guidance has PerkinElmer issued on next quarter's earnings?

PerkinElmer updated its FY18 earnings guidance on Monday, April, 30th. The company provided EPS guidance of $3.60 for the period, compared to the Thomson Reuters consensus estimate of $3.53.

What price target have analysts set for PKI?

14 equities research analysts have issued twelve-month price objectives for PerkinElmer's stock. Their predictions range from $65.00 to $90.00. On average, they anticipate PerkinElmer's share price to reach $76.9543 in the next year. View Analyst Ratings for PerkinElmer.

Who are some of PerkinElmer's key competitors?

Who are PerkinElmer's key executives?

PerkinElmer's management team includes the folowing people:
  • Mr. Robert F. Friel, Chairman, CEO & Pres (Age 62)
  • Mr. Frank A. Wilson, Sr. VP & CFO (Age 59)
  • Mr. Joel S. Goldberg, Sr. VP of Admin., Gen. Counsel & Sec. (Age 49)
  • Mr. James Corbett, Exec. VP & Pres of Discovery and Analytical Solutions (Age 55)
  • Mr. Prahlad R. Singh, Exec. VP & Pres of Diagnostics (Age 53)

Has PerkinElmer been receiving favorable news coverage?

News articles about PKI stock have trended somewhat positive this week, Accern Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. PerkinElmer earned a news sentiment score of 0.18 on Accern's scale. They also assigned media coverage about the medical research company an impact score of 50.21 out of 100, indicating that recent news coverage is somewhat likely to have an impact on the company's share price in the near term.

Who are PerkinElmer's major shareholders?

PerkinElmer's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Select Equity Group L.P. (7.27%), BlackRock Inc. (5.66%), Massachusetts Financial Services Co. MA (2.89%), King Luther Capital Management Corp (2.29%), Lord Abbett & CO. LLC (1.11%) and Northern Trust Corp (0.98%). Company insiders that own PerkinElmer stock include Alexis P Michas, Andrew Okun, Daniel R Tereau, Frank Anders Wilson, Joel S Goldberg, Kenton J Sicchitano, Nicholas A Lopardo, Patrick J Sullivan, Peter Barrett, Prahlad R Singh, Robert F Friel and Vicki L Sato. View Institutional Ownership Trends for PerkinElmer.

Which institutional investors are selling PerkinElmer stock?

PKI stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., Lord Abbett & CO. LLC, Robecosam AG, Ontario Teachers Pension Plan Board, Sector Gamma AS, Rothschild Asset Management Inc., Guggenheim Capital LLC and Westwood Holdings Group Inc.. Company insiders that have sold PerkinElmer company stock in the last year include Alexis P Michas, Andrew Okun, Daniel R Tereau, Frank Anders Wilson, Nicholas A Lopardo and Peter Barrett. View Insider Buying and Selling for PerkinElmer.

Which institutional investors are buying PerkinElmer stock?

PKI stock was purchased by a variety of institutional investors in the last quarter, including Select Equity Group L.P., Allianz Asset Management GmbH, Massachusetts Financial Services Co. MA, Echo Street Capital Management LLC, Sensato Investors LLC, Great Lakes Advisors LLC, Sivik Global Healthcare LLC and SG Americas Securities LLC. View Insider Buying and Selling for PerkinElmer.

How do I buy shares of PerkinElmer?

Shares of PKI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PerkinElmer's stock price today?

One share of PKI stock can currently be purchased for approximately $75.47.

How big of a company is PerkinElmer?

PerkinElmer has a market capitalization of $8.35 billion and generates $2.26 billion in revenue each year. The medical research company earns $292.63 million in net income (profit) each year or $2.90 on an earnings per share basis. PerkinElmer employs 11,000 workers across the globe.

How can I contact PerkinElmer?

PerkinElmer's mailing address is 940 WINTER STREET, WALTHAM MA, 02451. The medical research company can be reached via phone at 781-663-6900 or via email at [email protected]


MarketBeat Community Rating for PerkinElmer (PKI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  334 (Vote Outperform)
Underperform Votes:  346 (Vote Underperform)
Total Votes:  680
MarketBeat's community ratings are surveys of what our community members think about PerkinElmer and other stocks. Vote "Outperform" if you believe PKI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PKI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

PerkinElmer (NYSE:PKI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
14 Wall Street analysts have issued ratings and price targets for PerkinElmer in the last 12 months. Their average twelve-month price target is $76.9543, suggesting that the stock has a possible upside of 1.97%. The high price target for PKI is $90.00 and the low price target for PKI is $65.00. There are currently 1 sell rating, 9 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.212.232.312.20
Ratings Breakdown: 1 Sell Rating(s)
9 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
8 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $76.9543$76.9231$76.0833$68.2308
Price Target Upside: 1.97% upside1.98% upside8.06% downside3.56% downside

PerkinElmer (NYSE:PKI) Consensus Price Target History

Price Target History for PerkinElmer (NYSE:PKI)

PerkinElmer (NYSE:PKI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/1/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$85.00 ➝ $90.00HighView Rating Details
5/1/2018Bank of AmericaLower Price TargetNeutral ➝ Hold$86.00 ➝ $83.00HighView Rating Details
5/1/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$88.00 ➝ $82.00HighView Rating Details
5/1/2018Janney Montgomery ScottReiterated RatingBuy ➝ Fair Value$92.00 ➝ $73.36HighView Rating Details
4/9/2018Deutsche BankLower Price TargetHold ➝ Hold$85.00 ➝ $80.00LowView Rating Details
1/26/2018BarclaysBoost Price TargetUnderweight ➝ Underweight$69.00 ➝ $73.00LowView Rating Details
1/26/2018CowenReiterated RatingHold$84.00LowView Rating Details
1/3/2018Evercore ISIInitiated CoverageIn-Line$77.00LowView Rating Details
10/20/2017Jefferies GroupReiterated RatingHold$70.00N/AView Rating Details
9/26/2017Goldman SachsReiterated RatingNeutral ➝ Neutral$67.00LowView Rating Details
9/26/2017CitigroupReiterated RatingBuy$74.00 ➝ $80.00LowView Rating Details
8/4/2017Piper Jaffray CompaniesReiterated RatingBuy$81.00MediumView Rating Details
7/16/2017Cantor FitzgeraldReiterated RatingHoldLowView Rating Details
7/13/2017Wells FargoInitiated CoverageMarket Perform ➝ Market Perform$72.00LowView Rating Details
2/5/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
9/22/2016UBSReiterated RatingBuy$56.00 ➝ $61.00N/AView Rating Details
8/5/2016JPMorgan ChaseBoost Price TargetNeutral$52.00 ➝ $55.00N/AView Rating Details
8/5/2016MizuhoDowngradeBuy ➝ Neutral$56.00N/AView Rating Details
(Data available from 5/20/2016 forward)

Earnings

PerkinElmer (NYSE:PKI) Earnings History and Estimates Chart

Earnings by Quarter for PerkinElmer (NYSE:PKI)

PerkinElmer (NYSE:PKI) Earnings Estimates

2018 EPS Consensus Estimate: $3.59
2019 EPS Consensus Estimate: $4.04
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.61$0.61$0.61
Q2 20182$0.86$0.86$0.86
Q3 20182$0.91$0.93$0.92
Q4 20182$1.18$1.21$1.20
Q1 20192$0.71$0.92$0.82
Q2 20191$1.00$1.00$1.00
Q3 20192$0.99$1.00$1.00
Q4 20192$1.12$1.33$1.23

PerkinElmer (NYSE PKI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2018$0.87N/AView Earnings Details
4/30/2018Q1 2018$0.6110$0.63$618.97 million$644.00 millionViewListenView Earnings Details
1/25/2018Q4 2017$0.94$0.97$619.14 million$641.63 millionViewN/AView Earnings Details
11/2/2017Q3 2017$0.72$0.73$552.38 million$554.28 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.67$0.67$554.14 million$547.00 millionViewListenView Earnings Details
5/4/2017Q1 2017$0.54$0.55$506.81 million$514.12 millionViewListenView Earnings Details
2/2/2017Q4 2016$0.86$0.83$613.15 million$566.77 millionViewN/AView Earnings Details
11/7/2016Q3$0.66$0.68$572.03 million$548.00 millionViewListenView Earnings Details
8/4/2016Q2 2016$0.66$0.67$573.31 million$572.67 millionViewN/AView Earnings Details
5/5/2016Q116$0.51$0.56$532.55 million$538.70 millionViewN/AView Earnings Details
2/4/2016Q4 2015$0.87$0.86$616.70 million$608.12 millionViewN/AView Earnings Details
11/5/2015Q315$0.60$0.60$554.88 million$563.00 millionViewN/AView Earnings Details
7/30/2015Q2$0.59$0.60$555.66 million$564.00 millionViewListenView Earnings Details
4/30/2015Q115$0.46$0.50$537.27 million$526.90 millionViewN/AView Earnings Details
1/29/2015Q414$0.78$0.85$602.35 million$608.60 millionViewN/AView Earnings Details
10/30/2014Q3$0.57$0.67$550.40 million$542.05 millionViewListenView Earnings Details
8/7/2014Q2$0.59$0.59$572.26 million$556.20 millionViewListenView Earnings Details
4/24/2014Q114$0.44$0.46$531.31 million$531.90 millionViewListenView Earnings Details
1/30/2014Q413$0.70$0.73$588.95 million$594.00 millionViewListenView Earnings Details
10/30/2013Q313$0.48$0.49$523.84 million$524.30 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.48$0.51$532.95 million$543.30 millionViewListenView Earnings Details
4/25/2013Q1 2013$0.48$0.36$532.25 million$505.38 millionViewListenView Earnings Details
1/31/2013Q4 2012$0.65$0.65$577.94 million$577.00 millionViewListenView Earnings Details
10/25/2012$0.44$0.45ViewN/AView Earnings Details
8/2/2012$0.47$0.53ViewN/AView Earnings Details
4/26/2012$0.41$0.43ViewN/AView Earnings Details
2/2/2012$0.51$0.62ViewN/AView Earnings Details
11/3/2011$0.39$0.41ViewN/AView Earnings Details
8/4/2011$0.40$0.42ViewN/AView Earnings Details
5/5/2011$0.31$0.34ViewN/AView Earnings Details
2/3/2011$0.41$0.44ViewN/AView Earnings Details
11/4/2010Q3 2010$0.29$0.31ViewN/AView Earnings Details
8/5/2010Q2 2010$0.33$0.38ViewN/AView Earnings Details
5/6/2010Q1 2010$0.29$0.31ViewN/AView Earnings Details
2/4/2010Q4 2009$0.41$0.43ViewN/AView Earnings Details
10/29/2009Q3 2009$0.27$0.30ViewN/AView Earnings Details
7/30/2009Q2 2009$0.26$0.28ViewN/AView Earnings Details
4/30/2009Q1 2009$0.20$0.26ViewN/AView Earnings Details
1/29/2009Q4 2008$0.42$0.46ViewN/AView Earnings Details
10/23/2008Q3 2008$0.36$0.37ViewN/AView Earnings Details
7/24/2008Q2 2008$0.34$0.35ViewN/AView Earnings Details
4/24/2008Q1 2008$0.25$0.28ViewN/AView Earnings Details
1/24/2008Q4 2007$0.42$0.45ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

PerkinElmer (NYSE:PKI) Dividend Information

PerkinElmer pays an annual dividend of $0.28 per share, with a dividend yield of 0.37%. PKI's next quarterly dividend payment will be made on Friday, August 10. PerkinElmer pays out 9.66% of its earnings out as a dividend.
Next Dividend:8/10/2018
Annual Dividend:$0.28
Dividend Yield:0.37%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio(s):9.66% (Trailing 12 Months of Earnings)
7.76% (Based on This Year's Estimates)
6.93% (Based on Next Year's Estimates)
7.13% (Based on Cash Flow)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for PerkinElmer (NYSE:PKI)

PerkinElmer (NYSE:PKI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/26/2018quarterly$0.070.38%7/19/20187/20/20188/10/2018
1/26/2018quarterly$0.070.37%4/12/20184/13/20185/10/2018
10/27/2017quarterly$0.070.39%1/18/20181/19/20182/9/2018
7/24/2017quarterly$0.070.41%10/19/201710/20/201711/10/2017
4/28/2017quarterly$0.070.47%7/19/20177/21/20178/10/2017
1/27/2017quarterly$0.070.54%4/11/20174/14/20175/10/2017
10/26/2016quarterly$0.070.55%1/18/20171/20/20172/10/2017
7/27/2016quarterly$0.070.5%10/12/201610/14/201611/10/2016
4/25/2016quarterly$0.070.55%7/13/20167/15/20168/10/2016
1/28/2016quarterly$0.070.58%4/13/20164/15/20165/10/2016
10/29/2015quarterly$0.070.54%1/13/20161/15/20162/10/2016
7/23/2015quarterly$0.070.55%10/14/201510/16/201511/10/2015
4/27/2015quarterly$0.070.54%7/15/20157/17/20158/10/2015
1/23/2015quarterly$0.070.63%4/15/20154/17/20155/11/2015
10/23/2014quarterly$0.070.67%1/14/20151/16/20152/6/2015
7/24/2014quarterly$0.070.59%10/15/201410/17/201411/7/2014
4/22/2014quarterly$0.070.63%7/16/20147/18/20148/8/2014
1/24/2014quarterly$0.070.68%4/15/20144/18/20145/9/2014
10/24/2013quarterly$0.070.73%1/15/20141/17/20142/7/2014
7/26/2013quarterly$0.070.82%10/16/201310/18/201311/8/2013
6/13/2013quarterly$0.070.85%7/17/20137/19/20138/9/2013
1/25/2013quarterly$0.070.79%4/17/20134/19/20135/10/2013
(Data available from 1/1/2013 forward)

Insider Trades

PerkinElmer (NYSE PKI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.10%
Institutional Ownership Percentage: 91.81%
Insider Trading History for PerkinElmer (NYSE:PKI)
Insider Trading History for PerkinElmer (NYSE:PKI)

PerkinElmer (NYSE PKI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/18/2018Daniel R TereauInsiderSell1,156$77.00$89,012.006,784View SEC Filing  
3/5/2018Frank Anders WilsonInsiderSell103,656$73.94$7,664,324.6493,624View SEC Filing  
2/8/2018Andrew OkunInsiderSell2,324$75.44$175,322.568,876View SEC Filing  
2/5/2018Andrew OkunInsiderSell2,273$77.86$176,975.78View SEC Filing  
12/15/2017Andrew OkunInsiderSell12,680$72.00$912,960.0025,121View SEC Filing  
12/7/2017Frank Anders WilsonInsiderSell37,535$70.14$2,632,704.90View SEC Filing  
11/30/2017Alexis P MichasDirectorSell5,000$73.18$365,900.00View SEC Filing  
11/13/2017Peter BarrettDirectorSell7,071$71.07$502,535.9726,271View SEC Filing  
11/7/2017Nicholas A LopardoDirectorSell24,050$70.72$1,700,816.00View SEC Filing  
6/19/2017Andrew OkunInsiderSell4,358$65.00$283,270.0016,799View SEC Filing  
6/1/2017Peter BarrettDirectorSell10,000$63.22$632,200.0029,200View SEC Filing  
5/15/2017Patrick J SullivanDirectorSell6,628$62.59$414,846.5242,951View SEC Filing  
5/4/2017Robert F FrielInsiderSell25,100$60.00$1,506,000.00597,071View SEC Filing  
4/27/2017Robert F FrielInsiderSell124,837$60.11$7,503,952.07696,810View SEC Filing  
3/20/2017Andrew OkunInsiderSell3,000$57.27$171,810.0012,441View SEC Filing  
3/13/2017Joel S GoldbergInsiderSell30,710$55.45$1,702,869.5091,768View SEC Filing  
2/21/2017Alexis P. MichasDirectorSell8,308$55.60$461,924.80View SEC Filing  
2/15/2017Prahlad R SinghInsiderSell9,576$55.00$526,680.0016,319View SEC Filing  
2/9/2017Daniel R TereauInsiderSell5,001$53.16$265,853.1612,147View SEC Filing  
2/9/2017Vicki L SatoDirectorSell8,308$54.01$448,715.0838,278View SEC Filing  
2/6/2017Daniel R TereauInsiderSell4,069$52.01$211,628.699,465View SEC Filing  
12/1/2016Alexis P. MichasDirectorSell15,000$51.00$765,000.00View SEC Filing  
9/22/2016Joel S GoldbergInsiderSell38,095$55.00$2,095,225.0096,299View SEC Filing  
9/12/2016Daniel R TereauInsiderSell18,866$52.00$981,032.0021,241View SEC Filing  
8/24/2016Kenton J SicchitanoDirectorSell15,189$54.87$833,420.4343,160View SEC Filing  
8/17/2016Patrick J SullivanDirectorSell8,308$54.74$454,779.9241,829View SEC Filing  
6/2/2016Alexis P MichasDirectorSell1,953$54.85$107,122.0568,290View SEC Filing  
5/24/2016Robert F FrielCEOSell128,300$55.01$7,057,783.00690,831View SEC Filing  
5/16/2016Robert F FrielCEOSell109,000$55.01$5,996,090.00569,953View SEC Filing  
5/11/2016Robert F FrielCEOSell10,685$55.01$587,781.85573,216View SEC Filing  
5/10/2016Vicki L SatoDirectorSell12,586$54.51$686,062.8636,960View SEC Filing  
5/6/2016Robert F FrielCEOSell4,116$55.00$226,380.00566,647View SEC Filing  
4/18/2016Daniel R TereauInsiderSell2,158$50.79$109,604.828,602View SEC Filing  
3/21/2016James CorbettInsiderSell1,723$48.74$83,979.0228,881View SEC Filing  
2/24/2016Alexis P. MichasDirectorSell10,000$47.56$475,600.00View SEC Filing  
12/3/2015Kenton J SicchitanoDirectorSell10,216$51.05$521,526.8031,658View SEC Filing  
11/3/2015Frank Anders WilsoninsiderSell16,380$52.69$863,062.2055,859View SEC Filing  
10/23/2015Andrew OkunInsiderSell2,000$50.00$100,000.0011,278View SEC Filing  
9/14/2015James CorbettInsiderSell3,000$47.59$142,770.0021,664View SEC Filing  
9/3/2015Kenton J. SicchitanoDirectorSell12,586$47.88$602,617.6841,874View SEC Filing  
6/5/2015Alexis P MichasDirectorSell20,000$52.25$1,045,000.00View SEC Filing  
6/3/2015Frank Anders WilsonInsiderSell16,380$52.60$861,588.00View SEC Filing  
3/27/2015Joel S GoldbergInsiderSell10,646$51.00$542,946.00View SEC Filing  
3/23/2015Andrew OkunInsiderSell2,000$50.09$100,180.00View SEC Filing  
3/20/2015James CorbettInsiderSell5,157$50.23$259,036.11View SEC Filing  
3/18/2015Joel S GoldbergInsiderSell9,000$49.00$441,000.00View SEC Filing  
3/6/2015Patrick J SullivanDirectorSell12,586$46.90$590,283.40View SEC Filing  
3/5/2015Alexis P MichasDirectorSell8,892$47.00$417,924.00View SEC Filing  
3/5/2015Joel S GoldbergInsiderSell9,000$47.00$423,000.00View SEC Filing  
2/10/2015Vicki L SatoDirectorSell24,000$45.55$1,093,200.00View SEC Filing  
2/9/2015Andrew OkunInsiderSell6,262$45.82$286,924.84View SEC Filing  
2/3/2015Nicholas A LopardoDirectorSell8,892$46.30$411,699.60View SEC Filing  
2/3/2015Robert F FrielCEOSell60,709$46.26$2,808,398.34View SEC Filing  
2/2/2015Robert F FrielCEOSell319,065$46.02$14,683,371.30View SEC Filing  
11/14/2014James C MullenDirectorSell8,892$43.73$388,847.16View SEC Filing  
11/13/2014Patrick J SullivanDirectorSell8,892$43.46$386,446.32View SEC Filing  
9/4/2014Kenton J SicchitanoDirectorSell8,892$44.98$399,962.16View SEC Filing  
7/2/2014Daniel R MarshakSVPSell12,000$48.00$576,000.00View SEC Filing  
6/26/2014Daniel R MarshakSVPSell10,000$46.60$466,000.00View SEC Filing  
6/19/2014James CorbettInsiderSell57,126$46.69$2,667,212.94View SEC Filing  
6/9/2014Maurice H TenneyInsiderSell5,504$47.26$260,119.04View SEC Filing  
6/9/2014Robert F FrielCEOSell124,858$46.70$5,830,868.60View SEC Filing  
6/5/2014Alexis P MichasDirectorSell9,146$46.30$423,459.80View SEC Filing  
6/2/2014Alexis P MichasDirectorSell5,854$45.00$263,430.00View SEC Filing  
6/2/2014Joel S GoldbergInsiderSell17,000$45.11$766,870.00View SEC Filing  
5/12/2014Alexis MichasDirectorSell5,000$44.40$222,000.0096,321View SEC Filing  
4/29/2014Nicholas LopardoDirectorSell12,951$41.98$543,682.9878,622View SEC Filing  
4/7/2014James CorbettInsiderSell22,027$45.11$993,637.9721,858View SEC Filing  
3/12/2014Daniel MarshakSVPSell19,292$45.29$873,734.6845,445View SEC Filing  
3/11/2014John LetcherSVPSell41,000$45.40$1,861,400.0034,514View SEC Filing  
3/7/2014Andrew OkunCAOSell9,398$46.35$435,597.3013,816View SEC Filing  
2/27/2014Alexis MichasDirectorSell5,000$45.25$226,250.0095,067View SEC Filing  
2/14/2014Vicki SatoDirectorSell21,843$43.97$960,436.7145,370View SEC Filing  
2/7/2014James MullenDirectorSell12,951$43.73$566,347.2343,178View SEC Filing  
12/13/2013Maurice TenneyInsiderSell25,000$38.91$972,750.0026,109View SEC Filing  
12/10/2013Daniel MarshakSVPSell12,183$39.59$482,324.9742,762View SEC Filing  
11/14/2013Robert FrielCEOSell112,461$37.14$4,176,801.54516,849View SEC Filing  
9/10/2013Robert F FrielCEOSell141,000$37.45$5,280,450.00View SEC Filing  
9/6/2013Andrew OkunCAOSell6,805$36.86$250,832.30View SEC Filing  
5/1/2013Alexis P MichasDirectorSell6,440$30.85$198,674.00View SEC Filing  
4/30/2013James C MullenDirectorSell6,440$30.31$195,196.40View SEC Filing  
4/11/2013Maurice H TenneyInsiderSell9,500$35.00$332,500.00View SEC Filing  
9/13/2012Robert F FrielCEOSell50,565$29.00$1,466,385.00View SEC Filing  
8/9/2012Kenton J SicchitanoDirectorSell9,454$27.93$264,050.22View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

PerkinElmer (NYSE PKI) News Headlines

Source:
DateHeadline
PerkinElmer (PKI) Lifted to "Buy" at Zacks Investment ResearchPerkinElmer (PKI) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - May 17 at 3:09 PM
PerkinElmer (PKI) Cut to "Hold" at Zacks Investment ResearchPerkinElmer (PKI) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - May 16 at 1:35 PM
Global Automated Liquid Handling Market Growth Opportunities: Aurora Biomed, PerkinElmer IncGlobal Automated Liquid Handling Market Growth Opportunities: Aurora Biomed, PerkinElmer Inc
www.marketwatch.com - May 15 at 8:04 AM
Factors of Influence in 2018, Key Indicators and Opportunity within Cognex, MRC Global, Fulton Financial, Synovus Financial, PerkinElmer, and Cooper Tire & Rubber — New Research Emphasizes Economic GrowthFactors of Influence in 2018, Key Indicators and Opportunity within Cognex, MRC Global, Fulton Financial, Synovus Financial, PerkinElmer, and Cooper Tire & Rubber — New Research Emphasizes Economic Growth
finance.yahoo.com - May 14 at 8:03 AM
PerkinElmer to Present at UBS Global Healthcare Conference 2018PerkinElmer to Present at UBS Global Healthcare Conference 2018
finance.yahoo.com - May 8 at 5:59 PM
Elsevier Teams up With PerkinElmer to Enable Faster, More Intuitive Chemistry ResearchElsevier Teams up With PerkinElmer to Enable Faster, More Intuitive Chemistry Research
finance.yahoo.com - May 8 at 8:01 AM
$693.77 Million in Sales Expected for PerkinElmer (PKI) This Quarter$693.77 Million in Sales Expected for PerkinElmer (PKI) This Quarter
www.americanbankingnews.com - May 5 at 2:53 AM
PerkinElmer (PKI) Raised to Buy at Zacks Investment ResearchPerkinElmer (PKI) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - May 3 at 11:44 PM
Zacks: Brokerages Expect PerkinElmer (PKI) to Post $0.86 Earnings Per ShareZacks: Brokerages Expect PerkinElmer (PKI) to Post $0.86 Earnings Per Share
www.americanbankingnews.com - May 3 at 9:31 PM
PerkinElmer to Post FY2020 Earnings of $4.53 Per Share, Jefferies Group Forecasts (PKI)PerkinElmer to Post FY2020 Earnings of $4.53 Per Share, Jefferies Group Forecasts (PKI)
www.americanbankingnews.com - May 3 at 10:08 AM
Research Analysts Issue Forecasts for PerkinElmers FY2018 Earnings (PKI)Research Analysts Issue Forecasts for PerkinElmer's FY2018 Earnings (PKI)
www.americanbankingnews.com - May 3 at 8:56 AM
PerkinElmer (PKI) Downgraded by ValuEnginePerkinElmer (PKI) Downgraded by ValuEngine
www.americanbankingnews.com - May 2 at 10:54 PM
PerkinElmer to Post Q2 2018 Earnings of $0.86 Per Share, Jefferies Group Forecasts (PKI)PerkinElmer to Post Q2 2018 Earnings of $0.86 Per Share, Jefferies Group Forecasts (PKI)
www.americanbankingnews.com - May 2 at 8:56 AM
Q2 2018 Earnings Estimate for PerkinElmer (PKI) Issued By Piper JaffrayQ2 2018 Earnings Estimate for PerkinElmer (PKI) Issued By Piper Jaffray
www.americanbankingnews.com - May 2 at 8:28 AM
PKI Crosses Below Key Moving Average LevelPKI Crosses Below Key Moving Average Level
www.nasdaq.com - May 1 at 5:29 PM
Edited Transcript of PKI earnings conference call or presentation 30-Apr-18 9:00pm GMTEdited Transcript of PKI earnings conference call or presentation 30-Apr-18 9:00pm GMT
finance.yahoo.com - May 1 at 5:29 PM
PerkinElmer (PKI) Given New $90.00 Price Target at Morgan StanleyPerkinElmer (PKI) Given New $90.00 Price Target at Morgan Stanley
www.americanbankingnews.com - May 1 at 2:38 PM
PerkinElmer (PKI) PT Set at $83.00 by Bank of AmericaPerkinElmer (PKI) PT Set at $83.00 by Bank of America
www.americanbankingnews.com - May 1 at 1:28 PM
Robert W. Baird Trims PerkinElmer (PKI) Target Price to $82.00Robert W. Baird Trims PerkinElmer (PKI) Target Price to $82.00
www.americanbankingnews.com - May 1 at 10:42 AM
Janney Montgomery Scott Reaffirms "Fair Value" Rating for PerkinElmer (PKI)Janney Montgomery Scott Reaffirms "Fair Value" Rating for PerkinElmer (PKI)
www.americanbankingnews.com - May 1 at 9:13 AM
PerkinElmers (PKI) CEO Rob Friel on Q1 2018 Results - Earnings Call TranscriptPerkinElmer's (PKI) CEO Rob Friel on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 1 at 8:05 AM
PerkinElmer (PKI) Q1 Earnings & Revenues Top, 18 View UpPerkinElmer (PKI) Q1 Earnings & Revenues Top, '18 View Up
www.zacks.com - May 1 at 8:05 AM
PerkinElmer (PKI) Releases Quarterly  Earnings Results, Beats Expectations By $0.02 EPSPerkinElmer (PKI) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS
www.americanbankingnews.com - April 30 at 9:14 PM
PerkinElmer (PKI) Issues FY18 Earnings GuidancePerkinElmer (PKI) Issues FY18 Earnings Guidance
www.americanbankingnews.com - April 30 at 5:52 PM
PerkinElmer Q1 adjusted earnings Beat EstimatesPerkinElmer Q1 adjusted earnings Beat Estimates
www.nasdaq.com - April 30 at 5:26 PM
PerkinElmer beats by $0.02, beats on revenuePerkinElmer beats by $0.02, beats on revenue
seekingalpha.com - April 30 at 5:26 PM
PerkinElmer Raises FY18 Guidance - Quick FactsPerkinElmer Raises FY18 Guidance - Quick Facts
www.nasdaq.com - April 30 at 5:26 PM
PerkinElmer: 1Q Earnings SnapshotPerkinElmer: 1Q Earnings Snapshot
finance.yahoo.com - April 30 at 5:26 PM
PerkinElmer Announces Financial Results for the First Quarter of 2018PerkinElmer Announces Financial Results for the First Quarter of 2018
finance.yahoo.com - April 30 at 5:26 PM
PerkinElmer, Inc. to Host Earnings CallPerkinElmer, Inc. to Host Earnings Call
finance.yahoo.com - April 30 at 5:26 PM
PerkinElmer raises 2018 forecasts as 1st-qtr profit beats StreetPerkinElmer raises 2018 forecasts as 1st-qtr profit beats Street
finance.yahoo.com - April 30 at 5:26 PM
PerkinElmer first-quarter profit beats Street viewPerkinElmer first-quarter profit beats Street view
finance.yahoo.com - April 30 at 5:26 PM
PerkinElmer (PKI) to Issue Quarterly Dividend of $0.07PerkinElmer (PKI) to Issue Quarterly Dividend of $0.07
www.americanbankingnews.com - April 26 at 4:40 PM
PerkinElmer (PKI) Receives Average Rating of "Hold" from BrokeragesPerkinElmer (PKI) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - April 26 at 10:06 AM
Is a Surprise Coming for PerkinElmer (PKI) This Earnings Season?Is a Surprise Coming for PerkinElmer (PKI) This Earnings Season?
www.zacks.com - April 26 at 8:02 AM
PerkinElmer (PKI) Set to Announce Earnings on MondayPerkinElmer (PKI) Set to Announce Earnings on Monday
www.americanbankingnews.com - April 25 at 3:27 PM
PerkinElmer (PKI) to Release Earnings on WednesdayPerkinElmer (PKI) to Release Earnings on Wednesday
www.americanbankingnews.com - April 25 at 2:20 AM
Global Gas Chromatography Market Competitive landscape: Restek Corporation, R. Grace & Co., PerkinElmerGlobal Gas Chromatography Market Competitive landscape: Restek Corporation, R. Grace & Co., PerkinElmer
www.marketwatch.com - April 24 at 5:47 PM
PerkinElmer (PKI) Stock Rating Reaffirmed by CowenPerkinElmer (PKI) Stock Rating Reaffirmed by Cowen
www.americanbankingnews.com - April 20 at 8:01 PM
PerkinElmers (PKI) Hold Rating Reaffirmed at Jefferies GroupPerkinElmer's (PKI) Hold Rating Reaffirmed at Jefferies Group
www.americanbankingnews.com - April 20 at 7:28 PM
PerkinElmer (PKI) Insider Sells $89,012.00 in StockPerkinElmer (PKI) Insider Sells $89,012.00 in Stock
www.americanbankingnews.com - April 19 at 7:53 PM
Can Diagnostic Revenues Drive PerkinElmer (PKI) Q1 Earnings?Can Diagnostic Revenues Drive PerkinElmer (PKI) Q1 Earnings?
finance.yahoo.com - April 19 at 5:55 PM
PerkinElmer (PKI) Now Covered by Analysts at Wells FargoPerkinElmer (PKI) Now Covered by Analysts at Wells Fargo
www.americanbankingnews.com - April 18 at 1:56 PM
Q1 2018 EPS Estimates for PerkinElmer Boosted by Analyst (PKI)Q1 2018 EPS Estimates for PerkinElmer Boosted by Analyst (PKI)
www.americanbankingnews.com - April 18 at 7:52 AM
PerkinElmer (PKI) Expected to Post Quarterly Sales of $615.86 MillionPerkinElmer (PKI) Expected to Post Quarterly Sales of $615.86 Million
www.americanbankingnews.com - April 18 at 2:46 AM
Q3 2018 EPS Estimates for PerkinElmer (PKI) Boosted by Jefferies GroupQ3 2018 EPS Estimates for PerkinElmer (PKI) Boosted by Jefferies Group
www.americanbankingnews.com - April 17 at 6:40 AM
 Brokerages Anticipate PerkinElmer (PKI) Will Post Earnings of $0.61 Per Share Brokerages Anticipate PerkinElmer (PKI) Will Post Earnings of $0.61 Per Share
www.americanbankingnews.com - April 16 at 3:14 PM
New finance chief at PerkinElmerNew finance chief at PerkinElmer
seekingalpha.com - April 11 at 5:53 PM
PerkinElmer teams up with Helix to develop new molecular tests for consumersPerkinElmer teams up with Helix to develop new molecular tests for consumers
seekingalpha.com - April 11 at 5:53 PM
PerkinElmer (PKI) PT Lowered to $85.00PerkinElmer (PKI) PT Lowered to $85.00
www.americanbankingnews.com - April 11 at 9:23 AM

SEC Filings

PerkinElmer (NYSE:PKI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

PerkinElmer (NYSE:PKI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

PerkinElmer (NYSE PKI) Stock Chart for Sunday, May, 20, 2018

Loading chart…

This page was last updated on 5/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.